Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Surgical and Obstetric Outcomes in Patients With Uterine Malformations Undergoing Hysteroscopic Corrective Treatment 09/24/2024 OBSERVATIONAL unchanged 701.85 0 Comparison of Two Different Intensity Exercises on Young Women With Obesity 09/24/2024 INTERVENTIONAL unchanged 701.85 0 Acute Vitamin D Supplementation on Testosterone in Females 09/24/2024 INTERVENTIONAL unchanged 701.85 0 Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia 09/24/2024 OBSERVATIONAL unchanged 701.85 0 OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study 09/24/2024 INTERVENTIONAL unchanged 701.85 0 Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. 09/24/2024 INTERVENTIONAL unchanged 701.85 0 Glycemic Regulation as Endometriosis Adjunct Treatment 09/25/2024 INTERVENTIONAL unchanged 700.85 0 Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) 09/25/2024 INTERVENTIONAL unchanged 700.85 0 Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) 09/25/2024 INTERVENTIONAL unchanged 700.85 0 Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01) 09/25/2024 INTERVENTIONAL unchanged 700.85 0 Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer 09/25/2024 INTERVENTIONAL unchanged 700.85 0 PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer 09/25/2024 INTERVENTIONAL unchanged 700.85 0 Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections 09/26/2024 INTERVENTIONAL unchanged 699.85 0 Multimodal Rehabilitation Programme on Epigenetic Biomarkers, Quality of Life, Sexual Function and Muscle Strength in Women With Dyspareunia and Endometriosis. 09/26/2024 INTERVENTIONAL unchanged 699.85 0 Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study. 09/26/2024 OBSERVATIONAL unchanged 699.85 0 Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO) 09/26/2024 INTERVENTIONAL unchanged 699.85 0 Enhancing Care & Outcomes for Patients During the First Postpartum Year 09/26/2024 INTERVENTIONAL unchanged 699.85 0 The Impact of Vaginal Washing on Cervical Inflammation 09/26/2024 INTERVENTIONAL unchanged 699.85 0 Super-Hypofractionated Partial Breast Irradiation 09/26/2024 INTERVENTIONAL unchanged 699.85 0 Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up 09/27/2024 INTERVENTIONAL unchanged 698.85 0 Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens 09/27/2024 INTERVENTIONAL unchanged 698.85 0 Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities? 09/27/2024 OBSERVATIONAL unchanged 698.85 0 Cognitive-Behavioral Intervention to Increase Tummy Time Practice and Maintain Healthy Weight in Infants 09/27/2024 INTERVENTIONAL unchanged 698.85 0 Longitudinal FolloW-up of Antimicrobial Resistance From Perinatal Acquisition (LWAPA): A SHARE Study ASSESSING AND PREVENTING Antimicrobial Resistance in the Perinatal Period 09/27/2024 OBSERVATIONAL unchanged 698.85 0 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications. 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP) 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Trial of THEO-260 in Ovarian Cancer Patients 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Evaluation Of DNA Methylation Pattern In Healthy, Sarcopenic, Obese And Sarcopenic Obese Older Women: A Cross-Sectional Study 10/01/2024 OBSERVATIONAL unchanged 694.85 0 Safety of Administering Isoniazid to SLE Patients to Prevent TB 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Get Social Media and Risk-Reduction Training 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Exercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies 10/01/2024 OBSERVATIONAL unchanged 694.85 0 Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer 10/01/2024 INTERVENTIONAL unchanged 694.85 0 RCT Glargine vs NPH for Treatment of DM in Pregnancy 10/01/2024 INTERVENTIONAL unchanged 694.85 0 The Effect of Vaginal Speculum Type and Retention Time on Pregnancy Outcomes During The Embryo Transfer Process 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Alveolar Recruitment in Obese Patients in Major Gynaecological Cancer Surgery 10/01/2024 OBSERVATIONAL unchanged 694.85 0 eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer 10/01/2024 INTERVENTIONAL unchanged 694.85 0 High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Effect of Two Years of Resistance Training on Health Status in Postmenopausal Women: Longitudinal Study Active Aging. 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Ultrasound Assessment of Gastric Volume in Diabetic Versus Non-Diabetic Term Pregnant Women Undergoing Cesarean Section 10/01/2024 OBSERVATIONAL unchanged 694.85 0 Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies 10/01/2024 INTERVENTIONAL unchanged 694.85 0 Attitude Towards the Concept of CS on Demand 10/02/2024 OBSERVATIONAL unchanged 693.85 0 Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients 10/02/2024 OBSERVATIONAL unchanged 693.85 0 Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients 10/02/2024 INTERVENTIONAL unchanged 693.85 0 KNUCH CadAI-B-1(KCB-1) 10/02/2024 INTERVENTIONAL unchanged 693.85 0 The Impact of Breathing Training on PPSUI: A Randomized Controlled Trial 10/02/2024 INTERVENTIONAL unchanged 693.85 0 Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol 10/03/2024 INTERVENTIONAL unchanged 692.85 0 Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplicated Urinary Tract Infections: Diagnostic Accuracy in General Practice. 10/03/2024 OBSERVATIONAL unchanged 692.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology